AGIOS PHARMACEUTICALS, INC. (AGIO) › Capital ExpendituresAGIOS PHARMACEUTICALS, INC. (AGIO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $1.91M2012: $1.48M2013: $1.29M2014: $2.22M2015: $20.16M2016: $9.91M2017: $4.63M2018: $6.99M2019: $12.03M2020: $14.11M2021: $5.74M2022: $4.88M2023: $999.0K2024: $1.69M2025: $4.32M$4.32M2011Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$4.32M+156.1%2024$1.69M+68.7%2023$999.0K-79.5%2022$4.88M-15.0%2021$5.74M-59.3%2020$14.11M+17.3%2019$12.03M+72.2%2018$6.99M+51.0%2017$4.63M-53.3%2016$9.91M-50.8%2015$20.16M+809.9%2014$2.22M+71.3%2013$1.29M-12.3%2012$1.48M-22.6%2011$1.91M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share